The future of anticoagulation management in atrial fibrillation in Europe
Jun 1, 2015
Summary for healthcare professionals
|PDF file||0.2 MB||
Use Adobe Acrobat Reader version 10 or higher for the best experience.
As heart arrhythmia atrial fibrillation (AF) is becoming more prevalent, we explored current and future landscapes for AF-related stroke prevention. Key areas for the future include education of medical staff and engagement across health services.
This report is part of the RAND Corporation Research brief series. RAND research briefs present policy-oriented summaries of individual published, peer-reviewed documents or of a body of published work.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.